Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Join | Sign in
Home>Products>Product News
  Service News
Cirrus - Kemwell Receives FDA Grant
Thursday, October 10, 2013
Grant to evaluate formulation effects on MDI performance.

Aesica Extends Aseptic Facilities at Nottingham Site
Tuesday, October 08, 2013
Batches can be delivered worldwide for clinical trials and within the EU for small-scale commercial production.

4SC Presents Summary of Biomarker and Patient Subgroup Analysis of Prognostic Factors
Tuesday, October 01, 2013
Further information about proposed role of biomarker ZFP64 in HCC tumour progression presented.

Almac Offering TruSight Tumor Profiling Next-Generation Sequencing Service
Monday, September 30, 2013
TruSight Tumor™ panel is specifically designed for use with FFPE samples.

Almac Launches SupplyTraQ™ Technology Solution
Tuesday, September 24, 2013
Online tool enables more cost-efficient and accurate reconciliation and reporting.

Aptiv Solutions Launches ADDPLAN® DF
Monday, September 23, 2013
An innovative software for optimizing dose selection in phase 2 trials.

Smooth Drug Development Selects CRO Starter Kit™ CTMS by Flex Databases
Monday, September 23, 2013
Flex Databases to release an electronic data capture (EDC) product in Q4 2013.

Almac Launches Reusable Shipper Option for Temperature-Controlled Distribution
Friday, September 20, 2013
Reusable shippers greatly improve environmental impact and provide cost efficiencies.

New Partnership to Improve Clinical Trial Site Evaluation
Thursday, September 19, 2013
iCTRS partners with ViS Research to help trial planners benefit from a better, more efficient site selection process to accelerate development of much-needed medicines.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 298
Scientific News
Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.
NIH Works to Improve Kidney Health for All
Statement of NIDDK Director Griffin P. Rodgers, M.D., for World Kidney Day 2015.
MorphoSys and Emergent BioSolutions Initiate Phase 1 Clinical Study
Phase 1 study to evaluate the novel oncology immunotherapeutic MOR209/ES414 for prostate cancer.
NIH-supported Clinical Trials to Evaluate Long-acting, Injectable Antiretroviral Drugs
Both trials are expected to be completed in 2017.
Single-Cell, 42-plexed Protein Analysis Achieved with a New Microchip Technology
A novel microdevice capable of detecting 42 unique immune effector proteins has been developed.
Paramedics May be First Line of Treatment for Stroke
NIH study demonstrates feasibility of getting drugs to stroke patients faster.
Cancer Treatment with KU Origins Enters Second Clinical Trial
Cleave Biosciences has begun a Phase 1 clinical trial to evaluate CB-5083.
Ebola Vaccine Trial Opens in Liberia
Study led by Liberia-NIH partnership will test two experimental vaccines.
NIH Launches Tool to Advance Down Syndrome Research
Web portal will help approved professionals to plan clinical studies.
NIH Researchers Tackle Thorny Side of Gene Therapy
Pre-clinical studies in mice reveal ways to reduce cancer risk with modified treatment.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters